Compound: LJI308

Drug Target: RSK2, RSK1, RSK3

Drug Target pathway: PI3K/MTOR signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.